A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy Adults
Status:
Completed
Trial end date:
2017-11-13
Target enrollment:
Participant gender:
Summary
This is a Phase 2, randomized, double-blind, placebo-controlled single dose study in
otherwise healthy adults with acute uncomplicated seasonal influenza A to assess the safety
and tolerability, efficacy, and pharmacokinetics of MHAA4549A.